Detalhe da pesquisa
1.
Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease.
Clin Infect Dis
; 77(7): 1053-1062, 2023 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37249079
2.
Novel 6-Month Treatment for Drug-Resistant Tuberculosis, United States.
Emerg Infect Dis
; 27(1)2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33227229